WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2016> 32> 4

Volume: 32 Issue: 4

1. A clinical analysis of strengthening integrated traditional Chinese and Western medicine therapy for prevention and treatment of liver cancer Page:615—618
2. Clinical application of traditional Chinese medicine constitution theory in diagnosis and treatment of chronic hepatitis B Page:644—648
3. Neutrophil-lymphocyte ratio: a novel predictor of clinical outcome of patients with hepatocellular carcinoma Page:649—652
4. Efficacy of Baihe Xiaoyao powder in treatment of chronic hepatitis B with depression: a clinical analysis Page:653—656
5. Protective effect of Cordyceps militaris polypeptide against acute alcoholic liver injury in rats Page:669—672
6. Effect of ultrasound-guided percutaneous injection of cinobufotalin or anhydrous ethanol in treatment of portal vein tumor thrombus: a comparative analysis Page:673—677
7. Efficacy of peginterferon α-2a in treatment of chronic hepatitis B resistant to multiple nucleos(t)ide analogues Page:691—694
8. Prognostic risk factors in patients with hepatitis B virus-related acute-on-chronic liver failure Page:700—705
9. Clinical features of acute hepatitis B and acute exacerbation of chronic hepatitis B: a comparative study Page:706—710
10. Relationship between small intestinal bacterial overgrowth and severity of with hepatitis B cirrhosis Page:716—719
11. Correlation of liver stiffness measured by FibroScan with sex and age in healthy adults undergoing physical examination Page:724—727
12. Clinical features of drug-induced liver injury and primary biliary cirrhosis: a comparative analysis Page:728—731
13. Total laparoscopic hepatectomy versus open hepatectomy in treatment of hepatocellular carcinoma in the left lateral lobe: a case-matched analysis Page:735—738
14. Expression of NOB1 in liver cancer tissues and its significance Page:739—741
15. Efficacy of raltitrexed combined with transcatheter arterial chemoembolization in treatment of advanced colorectal cancer with liver metastasis Page:742—745
16. Ultrasonographic signs as factors for recurrence of gallstones and polypoid lesions of the gallbladder after gallbladder-preserving surgery Page:746—749
17. Effects of laparoscopic retrograde cholecystectomy versus partial cholecystectomy in treatment of complex bile duct diseases: a comparative analysis Page:750—753
18. A prognostic analysis of laparoscopic versus radical cholecystectomy for T1b unsuspected gallbladder carcinoma Page:754—757
19. Gallbladder-preserving cholelithotomy by laparoscopy and cholangioscopy for cholecystolithiasis Page:758—760
20. Efficacy of three liver-protecting drugs commonly used in treatment of drug-induced liver injury: a comparative analysis Page:761—763
21. Effect of PNPLA3 I148M mutation on expression of TGF-β1 in rat hepatic stellate cells Page:769—771
22. Application of external treatment of traditional Chinese medicine in cirrhotic ascites Page:781—784
23. Action of mechanism of traditional Chinese medicine in prevention and treatment of nonalcoholic fatty liver disease Page:785—789
24. A brief analysis of “the liver being an evil of Zang-organ” Page:790—792
25. Research advances in pharmacological effects of Ophiacordyceps sinensis in treatment of liver diseases Page:793—797
26. Research advances in sofosbuvir for treatment of chronic hepatitis C Page:798—801
27. Research advances in diagnosis and treatment of primary biliary cirrhosis Page:802—805
28. Role of pyruvate kinase muscle isozyme 2 in pathogenesis and diagnosis of liver cancer Page:806—810
29. Research advances in tumor markers of hepatocellular carcinoma Page:811—815
30. Research advances in sorafenib-induced apoptotic signaling pathways in liver cancer cells Page:816—820
31. Research advances in drug-induced liver injury in the elderly Page:821—824

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.